FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
FUSN
Delisted
FUSN was delisted on the 3rd of June, 2024.
29 hedge funds and large institutions have $88.8M invested in Fusion Pharmaceuticals Inc. Common Shares in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
Holders
29
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$158K | |
| 2 | +$98.5K | |
| 3 | +$59.2K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$24.5K |
| 5 |
Renaissance Technologies
New York
|
+$21.1K |
Top Sellers
| 1 | -$1.12M | |
| 2 | -$184K | |
| 3 | -$152K | |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$52K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$50.4K |